Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study evaluates if the combination of thermotherapy (one application, 50⁰C for 30\") and 3 weeks of miltefosine is safe and have a comparable cure rate with the current recommended first line treatments comprising meglumine antimoniate for 3 weeks for the treatment of uncomplicated cutaneous leishmaniasis cases in the New World.
Epistemonikos ID: f766c6d3d04e0415969513e88b876afff362af22
First added on: May 07, 2024